Showing results (541-550 of 1,837) with videos related to

Sort By:
Pageof 184
ESMO Open|April 26, 2021
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groupsD I Quinn, C F Ng, E Grande, et al.
ESMO Open|April 26, 2021
Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index <55%: single-arm phase II studyH Jeong, J Shin, J H Jeong, et al.
ESMO Open|March 29, 2023
Implementation of dihydropyrimidine dehydrogenase deficiency testing in EuropeM de With, A Sadlon, E Cecchin, et al.
ESMO Open|May 13, 2023
Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trialsC Mao, D Ji, Y Ding, et al.
ESMO Open|April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trialE de Guillebon, M Jimenez, L Mazzarella, et al.
ESMO Open|November 22, 2019
Molecular findings reveal possible resistance mechanisms in a patient with ALK-rearranged lung cancer: a case report and literature reviewAnastasia Kougioumtzi, Panagiotis Ntellas, Eirini Papadopoulou, et al.
ESMO Open|March 20, 2020
Safety, tolerability and clinical implementation of 'ready-to-use' 68gallium-DOTA0-Tyr3-octreotide (68Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)Prakash Manoharan, Angela Lamarca, Shaunak Navalkissoor, et al.
ESMO Open|December 5, 2019
Prognosis of early stage small cell bladder cancer is not always dismalJun Hao Lim, Santhanam Sundar
ESMO Open|December 5, 2019
Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancerToshiki Masuishi, Hiroya Taniguchi, Daisuke Kotani, et al.
ESMO Open|November 2, 2019
Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literatureGiuseppe Viscardi, Nicoletta Zanaletti, Maria Giovanna Ferrara, et al.
Pageof 184